|
|
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 3 联苯苄唑曲安奈德乳膏治疗炎症性浅表皮肤真菌病有效性和安全性的多中心、随机双盲、平行对照临床试验
[Translation] A multicenter, randomized, double-blind, parallel controlled clinical trial on the efficacy and safety of triamcinolone acetonide cream in the treatment of inflammatory superficial dermatophytosis
继续扩大样本量,确证联苯苄唑曲安奈德乳膏对治疗炎症性浅表皮肤真菌病(选择浅部真菌病中常见和多发的体股癣)的有效性和安全性,并以市售联苯苄唑乳膏(商品名“孚琪”)进行对照。
[Translation] Continue to expand the sample size to confirm the effectiveness and safety of bifonazole/triamcinolone acetonide cream in the treatment of inflammatory superficial skin fungal diseases (select tinea corporis and cruris, which are common and frequent superficial fungal diseases), and use the commercially available bifonazole cream (trade name "Fuqi") for comparison.
100 Clinical Results associated with Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
0 Patents (Medical) associated with Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
100 Deals associated with Liaoning Shengsheng Pharmaceutical Group Co., Ltd.
100 Translational Medicine associated with Liaoning Shengsheng Pharmaceutical Group Co., Ltd.